Small Animal Imaging Market To Witness Growth Based On Increased Number Of Pharmaceutical & Research Organizations & Technical Innovations Till 2025: Grand View Research,Inc.
Global Small Animal Imaging (In-Vivo) market is expected
to reach USD 2.7 billion by 2022, according to a new study by Grand View
Research, Inc. Growing number of medical conditions requiring accurate research
for development of treatment options is expected to enhance demand for small
animal imaging (in-Vivo) over the forecast period. Importance of these devices
in applications such as epigenetic research studies, drug receptor targeting,
and defining mechanism of action is estimated to provide potential growth
platform for this industry. The major factors driving the growth of small
animal imaging (in-vivo) market are growing usage of multi-functional
pre-clinical imaging, rising investments of CROs in pre-clinical studies,
increasing number of pharmaceutical and research organizations and technical
innovations such as high-resolution MRI with other modalities.
Browse full research report on Small Animal Imaging
Market: http://www.grandviewresearch.com/industry-analysis/small-animal-imaging-in-vivo-market
Further key findings from
the study suggest:
- Optical imaging dominated the technology segment in
2014 in terms of revenue share of over 45%. Advantages associated with
this technology such as easy and rapid operations and relatively lower
costs compared to other devices are the factors attributing for its high
share.
- Micro-MRI technology is expected to be the fastest
growing, and is expected to grow at a lucrative CAGR of over 12.0% by
2022. Micro-MRI has wide applications during functional and anatomical
analysis in developing mouse neonates and embryos.
- In term of applications, monitoring treatment
response, bio-distribution, cancer cell detection, biomarkers,
longitudinal studies and epigenetic studies are segments studied. In 2014,
Bio-distribution and monitoring the treatment response dominated the
overall market in terms of revenue share of over 33% and 25% respectively.
- The cancer cell detection segment is expected to show
prominent growth rate owing to the rising global prevalence of cancer, and
increasing government initiatives pertaining to cancer diagnostics research.
Cancer cell detection application is expected to generate revenue of over
USD 700 million by 2022, at a CAGR of over 12% from 2015 to 2022.
- North America dominated in terms of revenue in 2014
at 36.1% in 2014. Favorable platform for R&D pertaining to
technological advancements, vast pre-clinical research, established
healthcare infrastructure, and rising demand for rapid and advanced
methods are the key factors attributing for the highest revenue generation
in this region. European market held the second position owing to the
large number of pharmaceutical and clinical research organizations and
diagnostic device manufacturers.
- Asia Pacific regional market is expected to register
significant growth over the forecast period with CAGR of over 11% owing to
emerging economies, growing base of target population, and growing
clinical research activities. Additionally, rising acceptance level for
advanced medical devices is expected to provide potential growth platform
for key players of this market.
- The key players in this industry include Thermo
Fisher Scientific, Inc. Siemens AG, Mediso Medical Imaging Systems, Life
Technologies Corporation, Promega Corporation, Miltenyi Biotech GmbH,
Bruker Corporation, FujiFilm Holding Corporation, PerkinElmer Inc. and Aspect
Imaging Ltd. Companies are developing novel products to sustain their
market positions. For instance, Bruker Corporation has launched SKYSCAN
1176, In-vivo micro-CT, and Wrist MRI Machine from Aspect for effortless
imaging.
Browse more reports of this category by Grand View research:
http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global small animal
imaging (In-Vivo) market on the basis of medium and region:
Global Small Animal Imaging (In-Vivo) Technology
Outlook (Revenue, USD Million, 2012 - 2022)
- Micro-magnetic
resonance imaging
- Optical
imaging
- Nuclear
imaging
- Other
imaging modalities
Global Small Animal Imaging (In-Vivo) Application Outlook
(Revenue, USD Million, 2012 - 2022)
- Monitoring
treatment responseCancer cell detection
- Bio-distribution
- Biomarkers
- Longitudinal
studies
- Epigenetics
Small Animal Imaging (In-Vivo) Regional Outlook (Revenue,
USD Million, 2012 - 2022)
- North
America
- Europe
- Asia
Pacific
- RoW
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment